Literature DB >> 23303143

Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer.

Lifang Liu1, Valery E P P Lemmens, Ignace H J T De Hingh, Esther de Vries, Jan Anne Roukema, Monique E van Leerdam, Jan Willem Coebergh, Isabelle Soerjomataram.   

Abstract

BACKGROUND: Compared with the general population, patients with a previous colorectal cancer are at higher risk for a second colorectal cancer, but detailed risk analysis by subsite is scarce.
OBJECTIVE: Our goal was to investigate the risk of a second cancer in relation to subsite as a basis for planning surveillance strategies. DESIGN, SETTING, AND PATIENTS: This was a retrospective analysis of a prospectively designed, population-based cancer registry (The Netherlands Cancer Registry). Patients with a stage I, II, or III colorectal cancer diagnosed between 1989 and 2008 were included. MAIN OUTCOME MEASURES: Cumulative incidence, standardized incidence ratio, and absolute excess risk for second primary cancers in subsites of the colon and rectum were estimated for follow-up periods of 2 to 5, 6 to 10, and more than 10 years after the index cancer in patients older than 50 years and in those aged 50 years or younger.
RESULTS: A total of 123,347 patients had a first invasive colorectal cancer diagnosed between 1989 and 2008. Of these, 1849 patients (1.5%) had a second colorectal lesion that was found more than 1 year after the initial cancer and diagnosed as a second primary colorectal cancer. In patients older than 50 years, the 20-year cumulative incidence for second cancers was 3.4% in the proximal colon, 1.2% in the distal colon, and 1.2% in the rectum. More than 60% of second cancers occurred within 5 years after the index cancer. The standardized incidence ratio was highest in the proximal-colon (1.9; 95% CI, 1.8-2.0), followed by the distal-colon (1.0, 95% CI, 0.9-1.1), and the rectum (0.9, 95% CI, 0.8-1.0). The corresponding absolute excess risks per 10 000 person years were 9 in the proximal colon, 0.1 in the distal colon, and 1 in the rectum. After 5 years of follow-up, elevated risk was observed only in the proximal colon. A similar risk pattern was observed in patients younger than 50 years. The absolute excess risk for a second cancer in the proximal colon increased over time. The proportion of stage III and stage IV second cancers increased from 31% during the first 5 years of follow-up to 38% after 10 years of follow-up. LIMITATIONS: Limitations of this study included lack of data regarding polypectomy rates and interval of surveillance colonoscopies.
CONCLUSIONS: Compared with the general population, individuals with previous colorectal cancer have a higher risk for a second cancer in all subsites of the colon and rectum. Among long-term survivors older than 50 years, risk remains elevated only in the proximal colon. Further studies should be encouraged to develop a suitable surveillance method for aging, high-risk, long-term colorectal cancer survivors.

Entities:  

Mesh:

Year:  2013        PMID: 23303143     DOI: 10.1097/DCR.0b013e318279eb30

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  13 in total

1.  Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Charles J Kahi; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas J Robertson; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-02-12       Impact factor: 10.864

2.  Expression of granulocyte colony-stimulating factor receptor in rectal cancer.

Authors:  Xiao-Dong Yang; Ping Huang; Feng Wang; Ze-Kuan Xu
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

3.  Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease.

Authors:  H C Miller; P Drymousis; R Flora; R Goldin; D Spalding; A Frilling
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

4.  Risk factors for metachronous adenoma in patients with stage I/II colorectal cancer after radical surgery.

Authors:  Wenli Song; Zexian Chen; Zheyu Zheng; Zongjin Zhang; Yongle Chen; Xiaosheng He; Ping Lan; Jiancong Hu; Xiaowen He
Journal:  J Gastrointest Oncol       Date:  2021-04

5.  A 66-Year-Old Man Presenting with Port-Site Metastatic Gastric Adenocarcinoma 4 Years After Laparoscopic Resection of a Rectal Adenocarcinoma.

Authors:  Riyadh Hakami; Elham Alzahrani; Ahmed Binjaloud; Sulaiman Alshammari; Turki Alshammari; Amany A Fathaddin; Mohammed Ayesh Zayed; Maha-Hamadien Abdulla; Omar Al-Obeed
Journal:  Am J Case Rep       Date:  2022-05-04

6.  Health management in cancer survivors: Findings from a population-based prospective cohort study-the Yamagata Study (Takahata).

Authors:  Sho Nakamura; Hiroto Narimatsu; Yuriko Ito Sasahara; Ri Sho; Ryo Kawasaki; Hidetoshi Yamashita; Isao Kubota; Yoshiyuki Ueno; Takeo Kato; Takashi Yoshioka; Akira Fukao; Takamasa Kayama
Journal:  Cancer Sci       Date:  2015-10-30       Impact factor: 6.716

Review 7.  Next-generation sequencing: recent applications to the analysis of colorectal cancer.

Authors:  Filippo Del Vecchio; Valentina Mastroiaco; Antinisca Di Marco; Chiara Compagnoni; Daria Capece; Francesca Zazzeroni; Carlo Capalbo; Edoardo Alesse; Alessandra Tessitore
Journal:  J Transl Med       Date:  2017-12-08       Impact factor: 5.531

8.  Metachronous Granular Cell Tumor of the Descending Colon.

Authors:  Binav Shrestha; Mazin Khalid; Vijay Gayam; Osama Mukhtar; Shivani Thapa; Amrendra K Mandal; Jaspreet Kaler; Mowyad Khalid; Pavani Garlapati; Shamah Iqbal; Gerald Posner
Journal:  Gastroenterology Res       Date:  2018-02-08

9.  Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.

Authors:  Harindra Jayasekara; Jeanette C Reece; Daniel D Buchanan; Christophe Rosty; S Ghazaleh Dashti; Driss Ait Ouakrim; Ingrid M Winship; Finlay A Macrae; Alex Boussioutas; Graham G Giles; Dennis J Ahnen; Jan Lowery; Graham Casey; Robert W Haile; Steven Gallinger; Loic Le Marchand; Polly A Newcomb; Noralane M Lindor; John L Hopper; Susan Parry; Mark A Jenkins; Aung Ko Win
Journal:  Int J Cancer       Date:  2016-05-09       Impact factor: 7.316

10.  Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study.

Authors:  Aishah Coyte; David S Morrison; Philip McLoone
Journal:  BMC Cancer       Date:  2014-04-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.